Related Research Data
Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells.
Source:
Springer Science and Business Media LLC
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells
Source:
American Society of Hematology
Epithelial Junction Opener JO-1 Improves Monoclonal Antibody Therapy of Cancer
Source:
American Association for Cancer Research (AACR)
Cancer cell–selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules
Source:
Springer Science and Business Media LLC
Structural basis for EGF receptor inhibition by the therapeutic antibody IMC-11F8.
Source:
Elsevier BV
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
Source:
Springer Science and Business Media LLC
Phase 1 study of anti-epidermal growth factor receptor monoclonal antibody in patients with solid tumors.
Source:
Informa UK Limited
Characterization of the B Cell Epitopes Associated with a Truncated Form of Pseudomonas Exotoxin (PE38) Used to Make Immunotoxins for the Treatment of Cancer Patients
Source:
The American Association of Immunologists
Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes.
Source:
Springer Science and Business Media LLC
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
Source:
Springer Science and Business Media LLC
Phase I Trial of Continuous Infusion Anti-Mesothelin Recombinant Immunotoxin SS1P
Source:
American Association for Cancer Research (AACR)
Strategies and challenges for the next generation of therapeutic antibodies
Source:
Springer Science and Business Media LLC
Efficacy of the Anti-CD22 Recombinant Immunotoxin BL22 in Chemotherapy-Resistant Hairy-Cell Leukemia
Source:
Massachusetts Medical Society
Recombinant immunotoxin against B-cell malignancies with no immunogenicity in mice by removal of B-cell epitopes
Source:
Proceedings of the National Academy of Sciences
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
Source:
Massachusetts Medical Society
Target-cancer-cell-specific activatable fluorescence imaging probes: rational design and in vivo applications.
Source:
American Chemical Society (ACS)
Biosimilar, Biobetter, and Next Generation Antibody Characterization by Mass Spectrometry
Source:
American Chemical Society (ACS)
High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array
Source:
Royal Society of Chemistry (RSC)
Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity
Source:
Proceedings of the National Academy of Sciences
Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor.
Source:
American Society of Hematology
Trends in glycosylation, glycoanalysis and glycoengineering of therapeutic antibodies and Fc-fusion proteins.
Source:
Bentham Science Publishers Ltd.
Mesothelin targeted cancer immunotherapy.
Source:
Elsevier BV
Phase I Trial of Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) in Patients With B-Cell Malignancies
Source:
American Society of Clinical Oncology (ASCO)
Transwells with microstamped membranes produce micropatterned two-dimensional and three-dimensional co-cultures.
Source:
Mary Ann Liebert Inc
Analytical methods for physicochemical characterization of antibody drug conjugates
Source:
Informa UK Limited
Phase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox (CAT-8015 or HA22) in Patients With Hairy Cell Leukemia
Source:
American Society of Clinical Oncology (ASCO)
Targeting tumours with genetically enhanced T lymphocytes
Source:
Springer Science and Business Media LLC
Linking provided by
